scholarly journals Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

2018 ◽  
Vol Volume 12 ◽  
pp. 971-979 ◽  
Author(s):  
Louis Matza ◽  
Kristina Boye ◽  
Jessica Jordan ◽  
Kirsi Norrbacka ◽  
Raffaella Gentilella ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Patient Preferences ◽  
Health State ◽  
Weekly Injection ◽  
Health State Utilities

Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy

2019 ◽  
Vol 22 (8) ◽  
pp. 806-813 ◽  
Author(s):  
Kristina S. Boye ◽  
Louis S. Matza ◽  
Katie D. Stewart ◽  
Jessica Jordan ◽  
Giovanni Biricolti ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Patient Preferences ◽  
Health State ◽  
Health State Utilities

scholarly journals Health State Utilities Associated With Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes

2015 ◽  
Vol 18 (7) ◽  
pp. A363
Author(s):  
LS Matza ◽  
KD Stewart ◽  
EW Davies ◽  
R Paczkowski ◽  
KS Boye
Keyword(s):  
Type 2 Diabetes ◽  
Health State ◽  
Weekly Injection ◽  
Health State Utilities

Health State Utilities Associated with Attributes of Weekly Injection Devices and Subdermal Implant for Treatment of Type 2 Diabetes

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1114-P
Author(s):  
ANNE M. RENTZ ◽  
KATELYN CUTTS ◽  
KELLIE WASHINGTON ◽  
MAUD BEILLAT ◽  
KRISTINA YU-ISENBERG
Keyword(s):  
Type 2 Diabetes ◽  
Health State ◽  
Weekly Injection ◽  
Health State Utilities ◽  
Subdermal Implant

scholarly journals Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Louis S. Matza ◽  
Kristina S. Boye ◽  
Katie D. Stewart ◽  
Evan W. Davies ◽  
Rosirene Paczkowski
Keyword(s):  
Type 2 Diabetes ◽  
Health State ◽  
Weekly Injection ◽  
Health State Utilities

scholarly journals Health state utilities associated with weight loss in type 2 diabetes and obesity

2021 ◽  
pp. 1-20
Author(s):  
Kristina S. Boye ◽  
Louis S. Matza ◽  
Katie D. Stewart ◽  
Haylee Andrews ◽  
Timothy A. Howell ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Weight Loss ◽  
Health State ◽  
Health State Utilities ◽  
Diabetes And Obesity

scholarly journals Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes

2021 ◽  
Author(s):  
Louis S. Matza ◽  
Katelyn N. Cutts ◽  
Katie D. Stewart ◽  
Kirsi Norrbacka ◽  
Luis-Emilio García-Pérez ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Patient Preference ◽  
Treatment Process ◽  
Oral Treatment ◽  
Cost Utility ◽  
Health State ◽  
Dose Frequency ◽  
Treatment Processes ◽  
Health State Utilities

Abstract Purpose Previous research suggests that treatment process can have an influence on patient preference and health state utilities. This study examined preferences and estimated utilities for treatment processes of two daily oral treatment regimens and two weekly injectable regimens for treatment of type 2 diabetes (T2D). Methods Participants with T2D in the UK reported preferences and valued four health state vignettes in time trade-off utility interviews. The vignettes had identical descriptions of T2D but differed in treatment process: (1) daily simple oral treatment (tablets without administration requirements), (2) daily oral semaglutide (with administration requirements per product label), (3) weekly dulaglutide injection, (4) weekly semaglutide injection. Results Interviews were completed by 201 participants (52.7% male; mean age = 58.7). Preferences between treatment processes varied widely. Mean utilities were 0.890 for simple oral, 0.880 for oral semaglutide, 0.878 for dulaglutide injection, and 0.859 for semaglutide injection (with higher scores indicating greater preference). All pairwise comparisons found statistically significant differences between utilities (p < 0.01), except the comparison between oral semaglutide and the dulaglutide injection (p = 0.49). Conclusions Results suggest that routes of administration cannot be compared using only the simplest descriptions (e.g., oral versus injectable). Dose frequency and specific details of the treatment process administration had an impact on patient preference and health state utilities. The utilities estimated in this study may be useful in cost-utility models comparing these treatments for T2D. Results also suggest that it may be helpful to consider patient preferences for treatment process when selecting medications for patients in clinical settings.

scholarly journals Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment

2020 ◽  
Vol 23 (7) ◽  
pp. 842-850 ◽  
Author(s):  
Semra Ozdemir ◽  
Drishti Baid ◽  
Naina R. Verghese ◽  
Amanda YR. Lam ◽  
Phong Ching Lee ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Discrete Choice Experiment ◽  
Discrete Choice ◽  
Patient Preferences ◽  
Choice Experiment

scholarly journals Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy

2019 ◽  
Vol 11 (1) ◽  
pp. 319-330
Author(s):  
Louis S. Matza ◽  
Beatrice Osumili ◽  
Katie D. Stewart ◽  
Magaly Perez-Nieves ◽  
Jessica Jordan ◽  
...  
Keyword(s):  
Patient Preferences ◽  
Health State ◽  
Patients With Diabetes ◽  
Health State Utilities ◽  
Mealtime Insulin
Sign in / Sign up

Export Citation Format

Share Document